Martin Akerman

No. 494: In which Earth Day, the National League and fresh NSF Fellows all arrive, but COVID-19 won’t leave

  People of Earth: Welcome to Wednesday, dear readers, as Long Island, the United States and a good chunk of the civilized world muscle their way through another workweek in the Age of Coronavirus. It’s April 22 out there, which of course makes this Earth Day’s 50th anniversary – certainly not what anybody expected it would be, though maybe that’s not all bad. Cool beans: Meanwhile, you might still have some in the house after…


Envisagenics’ artificial intelligence wows real investors

By GREGORY ZELLER // They’re on a major roll at Envisagenics Inc., a Cold Spring Harbor Laboratory spinoff that’s piling up some hefty research grants. Now based in New York City, the biotech announced this week that it’s been awarded a $1.5 million Small Business Innovation Research Phase II grant from the National Institutes of Health – the second time the NIH has backed the data-crunching startup. The new award is earmarked for the continued…


Helping Big Pharma master Big Data

By GREGORY ZELLER // Medicine is making giant strides in the research of ribonucleic acid – RNA for short – a molecule that plays vital roles in the coding, decoding and regulation of genes. The stumbling block is the resulting data, which has been piling up from next-generation sequencing technology and will soon represent the largest collection of electronic bytes in the world, topping even the astronomical amounts of data collected on space. And even…